guest ::
| Home > Publications Database > The immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis. > print |
| Home > Publications Database > The immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis. > print |
| 001 | 280787 | ||
| 005 | 20250907001910.0 | ||
| 024 | 7 | _ | |a 10.1016/j.cell.2025.05.029 |2 doi |
| 024 | 7 | _ | |a pmid:40532699 |2 pmid |
| 024 | 7 | _ | |a 0092-8674 |2 ISSN |
| 024 | 7 | _ | |a 1097-4172 |2 ISSN |
| 024 | 7 | _ | |a altmetric:178143270 |2 altmetric |
| 037 | _ | _ | |a DZNE-2025-00971 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Woo, Marcel S |b 0 |
| 245 | _ | _ | |a The immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis. |
| 260 | _ | _ | |a [Cambridge, Mass.] |c 2025 |b Cell Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1756207020_31525 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Inflammation, aberrant proteostasis, and energy depletion are hallmarks of neurodegenerative diseases such as multiple sclerosis (MS). However, the interplay between inflammation, proteasomal dysfunction in neurons, and its consequences for neuronal integrity remains unclear. Using transcriptional, proteomic, and functional analyses of proteasomal subunits in inflamed neurons, we found that interferon-γ-mediated induction of the immunoproteasome subunit, proteasome 20S beta 8 (PSMB8) impairs the proteasomal balance, resulting in reduced proteasome activity. This reduction causes the accumulation of phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), a key metabolic regulator, leading to enhanced neuronal glycolysis, reduced pentose phosphate pathway activity, oxidative injury, and ferroptosis. Neuron-specific genetic and systemic pharmacological targeting of PSMB8 or PFKFB3 protected neurons in vitro and in a mouse model of MS. Our findings provide a unifying explanation for proteasomal dysfunction in MS and possibly other neurodegenerative diseases, linking inflammation to metabolic disruption, and presenting an opportunity for targeted neuroprotective therapies. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 536 | _ | _ | |a 351 - Brain Function (POF4-351) |0 G:(DE-HGF)POF4-351 |c POF4-351 |f POF IV |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a excitotoxicity |2 Other |
| 650 | _ | 7 | |a ferroptosis |2 Other |
| 650 | _ | 7 | |a glycolysis |2 Other |
| 650 | _ | 7 | |a immunoproteasome |2 Other |
| 650 | _ | 7 | |a interferon-γ |2 Other |
| 650 | _ | 7 | |a metabolism |2 Other |
| 650 | _ | 7 | |a multiple sclerosis |2 Other |
| 650 | _ | 7 | |a neurodegeneration |2 Other |
| 650 | _ | 7 | |a neuroinflammation |2 Other |
| 650 | _ | 7 | |a Proteasome Endopeptidase Complex |0 EC 3.4.25.1 |2 NLM Chemicals |
| 650 | _ | 7 | |a Phosphofructokinase-2 |0 EC 2.7.1.105 |2 NLM Chemicals |
| 650 | _ | 7 | |a Interferon-gamma |0 82115-62-6 |2 NLM Chemicals |
| 650 | _ | 7 | |a PFKFB3 protein, mouse |0 EC 2.7.1.105 |2 NLM Chemicals |
| 650 | _ | 7 | |a Psmb10 protein, mouse |0 EC 3.4.25.1 |2 NLM Chemicals |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Proteasome Endopeptidase Complex: metabolism |2 MeSH |
| 650 | _ | 2 | |a Proteasome Endopeptidase Complex: genetics |2 MeSH |
| 650 | _ | 2 | |a Multiple Sclerosis: metabolism |2 MeSH |
| 650 | _ | 2 | |a Multiple Sclerosis: pathology |2 MeSH |
| 650 | _ | 2 | |a Multiple Sclerosis: immunology |2 MeSH |
| 650 | _ | 2 | |a Neurons: metabolism |2 MeSH |
| 650 | _ | 2 | |a Neurons: pathology |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Phosphofructokinase-2: metabolism |2 MeSH |
| 650 | _ | 2 | |a Glycolysis |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Interferon-gamma: metabolism |2 MeSH |
| 650 | _ | 2 | |a Mice, Inbred C57BL |2 MeSH |
| 650 | _ | 2 | |a Inflammation: metabolism |2 MeSH |
| 650 | _ | 2 | |a Disease Models, Animal |2 MeSH |
| 650 | _ | 2 | |a Pentose Phosphate Pathway |2 MeSH |
| 650 | _ | 2 | |a Ferroptosis |2 MeSH |
| 650 | _ | 2 | |a Neurodegenerative Diseases: metabolism |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Encephalomyelitis, Autoimmune, Experimental |2 MeSH |
| 700 | 1 | _ | |a Brand, Johannes |b 1 |
| 700 | 1 | _ | |a Bal, Lukas C |b 2 |
| 700 | 1 | _ | |a Moritz, Manuela |b 3 |
| 700 | 1 | _ | |a Walkenhorst, Mark |b 4 |
| 700 | 1 | _ | |a Vieira, Vanessa |b 5 |
| 700 | 1 | _ | |a Ipenberg, Inbal |b 6 |
| 700 | 1 | _ | |a Rothammer, Nicola |b 7 |
| 700 | 1 | _ | |a Wang, Man |b 8 |
| 700 | 1 | _ | |a Dogan, Batuhan |b 9 |
| 700 | 1 | _ | |a Loreth, Desirée |b 10 |
| 700 | 1 | _ | |a Mayer, Christina |b 11 |
| 700 | 1 | _ | |a Nagel, Darwin |b 12 |
| 700 | 1 | _ | |a Wagner, Ingrid |b 13 |
| 700 | 1 | _ | |a Pfeffer, Lena Kristina |b 14 |
| 700 | 1 | _ | |a Landgraf, Peter |b 15 |
| 700 | 1 | _ | |a van Ham, Marco |b 16 |
| 700 | 1 | _ | |a Mattern, Kuno M-J |b 17 |
| 700 | 1 | _ | |a Winschel, Ingo |b 18 |
| 700 | 1 | _ | |a Frantz, Noah |b 19 |
| 700 | 1 | _ | |a Sonner, Jana K |b 20 |
| 700 | 1 | _ | |a Grosshans, Henrike K |b 21 |
| 700 | 1 | _ | |a Miguela, Albert |b 22 |
| 700 | 1 | _ | |a Bauer, Simone |b 23 |
| 700 | 1 | _ | |a Meurs, Nina |b 24 |
| 700 | 1 | _ | |a Müller, Anke |b 25 |
| 700 | 1 | _ | |a Binkle-Ladisch, Lars |b 26 |
| 700 | 1 | _ | |a Salinas, Gabriela |b 27 |
| 700 | 1 | _ | |a Jänsch, Lothar |b 28 |
| 700 | 1 | _ | |a Dieterich, Daniela C |b 29 |
| 700 | 1 | _ | |a Riedner, Maria |b 30 |
| 700 | 1 | _ | |a Krüger, Elke |b 31 |
| 700 | 1 | _ | |a Heppner, Frank L |0 P:(DE-2719)2812386 |b 32 |u dzne |
| 700 | 1 | _ | |a Glatzel, Markus |b 33 |
| 700 | 1 | _ | |a Puelles, Victor G |b 34 |
| 700 | 1 | _ | |a Engler, Jan Broder |b 35 |
| 700 | 1 | _ | |a Nyengaard, Jens Randel |b 36 |
| 700 | 1 | _ | |a Misgeld, Thomas |0 P:(DE-2719)2810727 |b 37 |u dzne |
| 700 | 1 | _ | |a Kerschensteiner, Martin |b 38 |
| 700 | 1 | _ | |a Merkler, Doron |b 39 |
| 700 | 1 | _ | |a Meyer-Schwesinger, Catherine |b 40 |
| 700 | 1 | _ | |a Friese, Manuel A |b 41 |
| 773 | _ | _ | |a 10.1016/j.cell.2025.05.029 |g Vol. 188, no. 17, p. 4567 - 4585.e32 |0 PERI:(DE-600)2001951-8 |n 17 |p 4567 - 4585.e32 |t Cell |v 188 |y 2025 |x 0092-8674 |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/280787/files/DZNE-2025-00971.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/280787/files/DZNE-2025-00971%20SUP.zip |
| 856 | 4 | _ | |u https://pub.dzne.de/record/280787/files/DZNE-2025-00971.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:pub.dzne.de:280787 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 32 |6 P:(DE-2719)2812386 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 37 |6 P:(DE-2719)2810727 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-351 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Brain Function |x 1 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2025-01-01 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL : 2022 |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2025-01-01 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-01 |
| 915 | _ | _ | |a IF >= 60 |0 StatID:(DE-HGF)9960 |2 StatID |b CELL : 2022 |d 2025-01-01 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2025-01-01 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-01 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2025-01-01 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-01 |
| 920 | 1 | _ | |0 I:(DE-2719)1810007 |k AG Heppner |l Neuroimmunology |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1110000-4 |k AG Misgeld |l Neuronal Cell Biology |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1810007 |
| 980 | _ | _ | |a I:(DE-2719)1110000-4 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|